Skip to main content

Table 3 Clinical and laboratory characteristics of the non-obese subjects (BMI <25 kg/m 2 )

From: Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study

 

Gout

Healthy

P

 

(n = 38)

(n = 150)

 

Age, years

52.6 ± 9.7

49.2 ± 10.8

0.06

Body mass index, kg/m2

23.4 (2.0)

22.7 (2.4)

0.127*

Visceral fat area, cm2

98.7 ± 19.3

91.0 ± 16.7

0.016

Visceral fat obesity, VFA ≥100 cm2

18 (47.4%)

41 (27.3%)

0.017

Waist circumference, cm

84.7 (6.8)

79.7 (8.5)

0.001*

Hip circumference, cm

92.9 ± 4.9

92.4 ± 3.7

0.403

Total fat mass, kg

14.3 (4.5)

13.5 (4.1)

0.271*

Total fat percentage, %

21.1 ± 4.7

20.4 ± 3.8

0.295

Systolic blood pressure, mmHg

122.5 ± 13.9

117.5 ± 13.1

0.049

Diastolic blood pressure, mmHg

80.0 (14.5)

74.0 (15.0)

0.070*

Uric acid, mg/dL

7.9 (1.3)

6.0 (1.3)

<0.001*

Total cholesterol, mg/dL

193.1 ± 33.8

190.5 ± 27.5

0.746

Triglyceride, mg/dL

127.0 (94.0)

81.0 (52.0)

<0.001*

High-density lipoprotein, mg/dL

46.5 (16.0)

51.0 (15.0)

0.008*

Low-density lipoprotein, mg/dL

114.5 (37.0)

115.0 (37.0)

0.919*

Glucose, mg/dL

97.3 ± 13.0

89.0 ± 6.8

<0.001

  1. *Non-parametric Mann-Whitney U-test was used.
  2. mean ± standard deviation or median (interquartile range).